Back to User profile » Dr Seitaro Omoto
Papers published by Dr Seitaro Omoto:
Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus
Nomura S, Shouzu A, Taniura T, Okuda Y, Omoto S, Suzuki M, Ito T, Toyoda N
Clinical Pharmacology: Advances and Applications 2023, 15:41-55
Published Date: 25 May 2023
Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)
Nomura S, Taniura T, Shouzu A, Omoto S, Suzuki M, Okuda Y, Ito T
Vascular Health and Risk Management 2018, 14:225-232
Published Date: 18 September 2018
Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
Okuda Y, Omoto S, Taniura T, Shouzu A, Nomura S
International Journal of General Medicine 2016, 9:65-71
Published Date: 12 April 2016
Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A,Nomura S
Diabetes, Metabolic Syndrome and Obesity 2015, 8:339-345
Published Date: 27 July 2015